237 related articles for article (PubMed ID: 21486277)
1. Methyl jasmonate down-regulates survivin expression and sensitizes colon carcinoma cells towards TRAIL-induced cytotoxicity.
Raviv Z; Zilberberg A; Cohen S; Reischer-Pelech D; Horrix C; Berger MR; Rosin-Arbesfeld R; Flescher E
Br J Pharmacol; 2011 Nov; 164(5):1433-44. PubMed ID: 21486277
[TBL] [Abstract][Full Text] [Related]
2. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.
Stolfi C; Caruso R; Franzè E; Rizzo A; Rotondi A; Monteleone I; Fantini MC; Pallone F; Monteleone G
Mol Cancer Ther; 2011 Oct; 10(10):1969-81. PubMed ID: 21817114
[TBL] [Abstract][Full Text] [Related]
3. Methyl jasmonate sensitizes human bladder cancer cells to gambogic acid-induced apoptosis through down-regulation of EZH2 expression by miR-101.
Wang Y; Xiang W; Wang M; Huang T; Xiao X; Wang L; Tao D; Dong L; Zeng F; Jiang G
Br J Pharmacol; 2014 Feb; 171(3):618-35. PubMed ID: 24490857
[TBL] [Abstract][Full Text] [Related]
4. J7, a methyl jasmonate derivative, enhances TRAIL-mediated apoptosis through up-regulation of reactive oxygen species generation in human hepatoma HepG2 cells.
Park C; Jin CY; Hwang HJ; Kim GY; Jung JH; Kim WJ; Yoo YH; Choi YH
Toxicol In Vitro; 2012 Feb; 26(1):86-93. PubMed ID: 22079975
[TBL] [Abstract][Full Text] [Related]
5. Methyl jasmonate abolishes the migration, invasion and angiogenesis of gastric cancer cells through down-regulation of matrix metalloproteinase 14.
Zheng L; Li D; Xiang X; Tong L; Qi M; Pu J; Huang K; Tong Q
BMC Cancer; 2013 Feb; 13():74. PubMed ID: 23394613
[TBL] [Abstract][Full Text] [Related]
6. Paxilline enhances TRAIL-mediated apoptosis of glioma cells via modulation of c-FLIP, survivin and DR5.
Kang YJ; Kim IY; Kim EH; Yoon MJ; Kim SU; Kwon TK; Choi KS
Exp Mol Med; 2011 Jan; 43(1):24-34. PubMed ID: 21150246
[TBL] [Abstract][Full Text] [Related]
7. 3-Bromopyruvate potentiates TRAIL-induced apoptosis in human colon cancer cells through a reactive oxygen species- and caspase-dependent mitochondrial pathway.
Abbaszadeh H; Valizadeh A; Mahdavinia M; Teimoori A; Pipelzadeh MH; Zeidooni L; Alboghobeish S
Can J Physiol Pharmacol; 2019 Dec; 97(12):1176-1184. PubMed ID: 31491344
[TBL] [Abstract][Full Text] [Related]
8. Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin.
Milrot E; Jackman A; Kniazhanski T; Gonen P; Flescher E; Sherman L
Cancer Lett; 2012 Jun; 319(1):31-8. PubMed ID: 22198483
[TBL] [Abstract][Full Text] [Related]
9. PI3K/Akt pathway activation attenuates the cytotoxic effect of methyl jasmonate toward sarcoma cells.
Elia U; Flescher E
Neoplasia; 2008 Nov; 10(11):1303-13. PubMed ID: 18953440
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase inhibition enhances TRAIL-induced human colon cancer cell apoptosis through AKT/FOXO3a-dependent upregulation of death receptors.
Shoeb M; Ramana KV; Srivastava SK
Free Radic Biol Med; 2013 Oct; 63():280-90. PubMed ID: 23732517
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells.
Sinicrope FA; Penington RC; Tang XM
Clin Cancer Res; 2004 Dec; 10(24):8284-92. PubMed ID: 15623604
[TBL] [Abstract][Full Text] [Related]
12. Galectin-1 Modulates the Survival and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Sensitivity in Human Hepatocellular Carcinoma Cells.
Li J; Sun RR; Yu ZJ; Liang H; Shen S; Kan Q
Cancer Biother Radiopharm; 2015 Oct; 30(8):336-41. PubMed ID: 26348206
[TBL] [Abstract][Full Text] [Related]
13. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
Kauntz H; Bousserouel S; Gossé F; Raul F
Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
[TBL] [Abstract][Full Text] [Related]
14. The anti-cancer activities of jasmonates.
Raviv Z; Cohen S; Reischer-Pelech D
Cancer Chemother Pharmacol; 2013 Feb; 71(2):275-85. PubMed ID: 23196641
[TBL] [Abstract][Full Text] [Related]
15. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
16. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
Lu M; Strohecker A; Chen F; Kwan T; Bosman J; Jordan VC; Cryns VL
Clin Cancer Res; 2008 May; 14(10):3168-76. PubMed ID: 18483385
[TBL] [Abstract][Full Text] [Related]
17. Aplysin sensitizes cancer cells to TRAIL by suppressing P38 MAPK/survivin pathway.
Liu J; Ma L; Wu N; Liu G; Zheng L; Lin X
Mar Drugs; 2014 Sep; 12(9):5072-88. PubMed ID: 25257790
[TBL] [Abstract][Full Text] [Related]
18. AN N-terminal Smac peptide sensitizes human prostate carcinoma cells to methyl jasmonate-induced apoptosis.
Jiang G; Zhao J; Xiao X; Tao D; Gu C; Tong Q; Luo B; Wang L; Zeng F
Cancer Lett; 2011 Mar; 302(1):37-46. PubMed ID: 21237556
[TBL] [Abstract][Full Text] [Related]
19. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.
Sung B; Ravindran J; Prasad S; Pandey MK; Aggarwal BB
J Biol Chem; 2010 Nov; 285(46):35418-27. PubMed ID: 20837473
[TBL] [Abstract][Full Text] [Related]
20. miR-494 Sensitizes Gastric Cancer Cells to TRAIL Treatment Through Downregulation of Survivin.
Xu S; Li D; Li T; Qiao L; Li K; Guo L; Liu Y
Cell Physiol Biochem; 2018; 51(5):2212-2223. PubMed ID: 30537730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
